医用一氧化二氮市场- 按类型（液体一氧化二氮、气态一氧化二氮）、应用（麻醉和止痛、冷冻手术、手术吹气）、最终用途（医院、家庭护理场所） - 全球预测（ 2024 - 2032）

在紧急医疗服务需求的推动下，2024年至2032年全球医用一氧化二氮市场的复合年增长率将超过7.4%。一氧化二氮透过提供有效的疼痛缓解和镇静作用，在紧急医疗服务中发挥至关重要的作用，特别是在门诊环境中。其起效快、作用可逆，使其成为紧急情况下治疗急性疼痛和焦虑的首选。随着医疗机构努力提高患者护理水平和效率，对一氧化二氮的需求持续增长。这一趋势得到了其经过验证的安全性和易于管理的支持，使其成为急诊医学的资产。对一氧化二氮的日益依赖凸显了其在确保传统医院环境之外及时有效的医疗干预方面的重要性。

举个例子，2024 年 7 月，Pinnacle Industries 推出了一款半高级型号 AD-Gen 救护车，旨在加强全国范围内的紧急医疗运输。儘管财政限制限制了车队升级和技术进步，但此次发布强调了其目标是改善印度高品质紧急医疗服务的可近性。

整个医用一氧化二氮产业根据类型、应用、最终用途和地区进行细分。

由于其在麻醉和疼痛管理方面的效率，到 2032 年，液体一氧化二氮细分市场将占据大量医用一氧化二氮市场。与气态一氧化二氮相比，液态一氧化二氮具有更容易储存、处理和精确剂量管理等优点。这使其成为精确麻醉至关重要的医疗环境中的首选。此外，医用气体输送系统的进步提高了液态一氧化二氮的安全性和有效性，促进了其在全球外科手术和医疗中的应用。

由于其作为低温剂的有效性，到 2032 年，冷冻外科领域在医用一氧化二氮市场上将实现令人印象深刻的复合年增长率。一氧化二氮能够达到极低的温度 -88.48°C，使其适合冷冻和破坏异常组织生长，例如疣、皮赘和某些类型的皮肤癌。与传统手术方法相比，这种非侵入性方法最大限度地减少了对周围健康组织的损害，并为患者提供了更快的恢復时间。随着冷冻手术因其功效和最小副作用而获得认可，全球医疗实践中对一氧化二氮作为低温剂的需求持续增长。

由于严格的医疗法规强调病人安全和有效的麻醉管理，欧洲医用一氧化二氮市场将在 2024 年至 2032 年呈现强劲的复合年增长率。欧洲医疗机构越来越多地采用先进的医疗技术和工艺，促进了一氧化二氮在外科手术和疼痛管理中的使用。此外，不断增加的医疗基础设施投资和扩大医疗保健覆盖范围有助于提高利用一氧化二氮进行医疗的机会。这些发展反映出人们对高效可靠的麻醉解决方案的日益青睐，从而增加了对医用一氧化二氮的需求。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
  • 增加外科手术和牙科手术
  • 慢性病盛行率上升
  • 各种医学专业越来越多地采用一氧化二氮
  • 老年人口不断增加
  • 产业陷阱与挑战
  • 替代方案的可用性
  • 滥用一氧化二氮相关的潜在风险
• 成长潜力分析
• 技术景观
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按类型，2021 - 2032

• 主要趋势
• 液体一氧化二氮
• 气态一氧化二氮

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 麻醉和缓解疼痛
• 冷冻手术
• 手术吹气

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 家庭护理设置
• 学术及研究机构

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Air Liquide
• Calix, Inc.
• Chengdu Taiyo Industrial Gases Co., Ltd.
• Ellenbarrie Industrial Gases Ltd.
• Linde Plc
• Mitsubishi Chemical Group Corporation
• Norco Inc.
• NEXAIR
• Oxygen & Argon Works Ltd.
• Steelman Gases Pvt. Ltd.
• SOL S.p.A.
• The Southern Gas Limited

Global Medical Nitrous Oxide Market will exhibit over 7.4% CAGR from 2024 to 2032, propelled by demand in emergency medical services. Nitrous oxide plays a crucial role in emergency medical services by providing effective pain relief and sedation, particularly in ambulatory settings. Its quick onset and reversible effects make it a preferred option for managing acute pain and anxiety in emergencies. As healthcare facilities strive to enhance patient care and efficiency, the demand for nitrous oxide continues to rise. This trend is supported by its proven safety profile and ease of administration, making it an asset in emergency medicine. The increasing reliance on nitrous oxide underscores its significance in ensuring prompt and effective medical interventions outside traditional hospital settings.

Quoting an instance, in July 2024, Pinnacle Industries launched a semi-premium variant, the AD-Gen Ambulance, aimed at enhancing emergency medical transportation nationwide. This launch emphasizes its goal to improve accessibility to high-quality emergency medical services in India despite financial constraints limiting fleet upgrades and technological advancements.

The overall medical nitrous oxide industry is segmented based on type, application, end-use, and region.

The liquid nitrous oxide segment will capture a substantial medical nitrous oxide market share by 2032 due to its efficiency in anesthesia and pain management. Liquid nitrous oxide offers advantages such as easier storage, handling, and precise dosage administration compared to gaseous forms. This makes it a preferred choice in medical settings where accurate delivery of anesthesia is crucial. Additionally, advancements in medical gas delivery systems have enhanced the safety and efficacy of liquid nitrous oxide, boosting its adoption in surgical procedures and medical treatments worldwide.

The cryosurgery segment will register an impressive CAGR in the medical nitrous oxide market through 2032, owing to its effectiveness as a cryogenic agent. Nitrous oxides ability to reach very low temperatures -88.48°C makes it suitable for freezing and destroying abnormal tissue growths, such as warts, skin tags, and certain types of skin cancer. This non-invasive approach minimizes damage to surrounding healthy tissue and offers patients a quicker recovery time compared to traditional surgical methods. As cryosurgery gains recognition for its efficacy and minimal side effects, the demand for nitrous oxide as a cryogenic agent continues to grow in medical practices globally.

Europe medical nitrous oxide market will demonstrate a robust CAGR from 2024 to 2032 because of strict healthcare regulations emphasizing patient safety and effective anesthesia management. The increasing adoption of advanced medical technologies and techniques across European healthcare facilities has bolstered the use of nitrous oxide in surgical procedures and pain management. Moreover, growing investments in healthcare infrastructure and expanding healthcare coverage contribute to greater accessibility to medical treatments utilizing nitrous oxide. These developments reflect a growing preference for efficient and reliable anesthesia solutions, increasing the demand for medical nitrous oxide.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Increasing surgical procedures and dental procedures
  • 3.2.3 Rising prevalence of chronic diseases
  • 3.2.4 Growing adoption of nitrous oxide across various medical specialties
  • 3.2.5 Rising geriatric population
  • 3.2.6 Industry Pitfalls & Challenges
  • 3.2.7 Availability of alternatives
  • 3.2.8 Potential risks associated with nitrous oxide misuse
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Liquid nitrous oxide
• 5.3 Gaseous nitrous oxide

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Anesthesia and pain relief
• 6.3 Cryosurgery
• 6.4 Surgical insufflation

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Home care settings
• 7.4 Academic and research institutes

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East And Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Air Liquide
• 9.2 Calix, Inc.
• 9.3 Chengdu Taiyo Industrial Gases Co., Ltd.
• 9.4 Ellenbarrie Industrial Gases Ltd.
• 9.5 Linde Plc
• 9.6 Mitsubishi Chemical Group Corporation
• 9.7 Norco Inc.
• 9.8 NEXAIR
• 9.9 Oxygen & Argon Works Ltd.
• 9.10 Steelman Gases Pvt. Ltd.
• 9.11 SOL S.p.A.
• 9.12 The Southern Gas Limited